Amn healthcare services, inc. (AMN)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net Income (Loss) Attributable to Parent

92,831

113,988

122,119

126,522

133,182

141,741

147,295

147,505

143,231

132,558

117,742

116,910

111,977

105,838

99,652

106,003

95,551

81,891

71,621

46,473

37,796

33,217

31,678

31,794

33,000

32,933

31,660

28,903

20,423

17,136

7,618

-25,139

-24,245

-26,265

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

67,044

58,520

52,962

47,173

45,061

41,237

38,308

35,144

32,497

32,279

31,491

31,148

30,523

29,620

27,210

24,725

22,623

20,953

19,708

18,490

17,268

15,993

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

0

Non-cash interest expense and other

-616

-1,984

6,066

4,698

4,784

4,841

-3,358

-2,075

-2,210

-2,231

2,954

2,812

2,419

2,416

1,669

1,668

2,053

1,934

1,733

1,707

1,554

1,392

1,390

1,336

1,336

1,336

1,625

2,052

2,064

2,921

3,304

3,470

4,003

3,787

0

0

0

Change in fair value of contingent consideration

8,078

7,178

1,190

-4,577

-3,100

-2,400

-1,189

157

161

184

130

-192

-100

-24

-118

-116

-231

-330

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in allowance for credit losses and sales credits

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in allowances for doubtful accounts and sales credits

-

-

-

-

-

9,006

7,567

7,408

7,188

10,339

14,274

14,296

14,729

12,008

8,115

8,061

7,179

6,684

6,793

6,315

6,142

4,393

4,864

5,133

3,969

4,628

4,163

4,981

5,882

6,786

6,749

5,835

5,333

4,411

0

0

0

Provision for deferred income taxes

10,682

913

-1,983

-3,822

-4,590

-667

12,735

7,458

5,394

5,607

-15,727

-18,029

-13,123

-9,424

-8,215

6,029

6,117

12,677

27,694

19,082

15,253

11,779

2,848

1,095

3,893

3,031

4,455

6,486

4,914

6,951

3,347

-1,003

-73

-1,795

0

0

0

Share-based Payment Arrangement, Noncash Expense

15,982

16,241

14,574

13,558

13,137

10,815

10,471

11,139

10,420

10,237

10,324

10,551

10,699

11,399

12,528

11,845

11,288

10,284

8,347

8,117

7,715

7,157

0

0

0

-

0

0

0

-

-

-

-

-

0

0

0

Share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,224

0

0

0

-

-

-

-

Excess tax benefit from equity awards vested and exercised

-

-

-

-

-

-

-

-

-

-

-

-

-

3,351

2,944

3,402

4,742

7,449

7,308

6,914

5,302

1,819

1,772

1,806

2,363

1,521

1,561

1,464

742

44

13

26

114

109

0

0

0

Gain on sale of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,187

1,187

1,187

1,187

0

0

0

0

Loss on disposal or sale of fixed assets

-3,746

-484

-526

-117

-116

-117

-137

-223

-167

-227

-154

-89

-134

-69

-46

-27

-6

-4

-13

-56

-57

-60

-51

-10

-7

-14

-29

-26

-40

-32

-24

-49

-63

-108

0

0

0

Write-off of fees on credit facilities

-

-

-

-

-

-574

-574

-574

-574

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of discount on investments

228

298

400

369

307

202

93

147

142

127

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net gain on deferred compensation balances

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash lease expense

82

-5

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable

-23,992

-28,278

-22,950

2,856

12,107

1,453

7,484

4,668

11,491

18,858

26,737

17,626

41,694

58,700

71,515

89,748

74,429

75,653

69,174

63,116

54,595

41,958

23,058

5,889

-2,892

8,644

7,215

18,244

21,017

2,642

4,692

3,416

9,314

23,601

0

0

0

Accounts receivable, subcontractor

20,330

22,571

17,862

15,402

16,581

9,131

7,691

-1,974

-9,811

-8,221

-4,894

-9,696

-1,021

-1,542

-7,394

9,451

15,701

22,365

27,952

14,397

15,511

10,172

2,700

6,784

-652

-196

-817

-6,268

-4,008

-4,030

2,245

6,294

5,000

5,415

0

0

0

Income taxes receivable

-721

4,464

1,299

560

-6,017

-15,099

686

726

6,017

15,537

1,545

-196

-824

-6,469

-13,019

-8,112

-8,702

-7,867

-1,292

-3,892

-2,825

-768

0

0

0

-

-

-

-

-

-

-

-

-388

0

0

0

Prepaid expenses

1,502

-774

-3,249

-4,954

-1,453

-4,465

-1,661

1,364

-618

2,316

1,903

1,406

3,295

455

897

2,231

2,642

2,915

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current assets

-8,093

-2,847

373

63

5,867

1,259

1,353

-2,332

-6,860

-4,301

-10,547

-3,084

3,919

5,662

9,407

7,175

6,565

5,409

3,458

623

-5,667

-1,920

2,055

2,683

-2,227

-3,859

647

2,203

5,853

8,684

3,301

2,567

3,367

825

0

0

0

Other assets

4,140

12,751

2,532

4,080

874

-5,239

1,221

-913

2,356

5,406

4,471

5,283

4,230

3,562

5,626

6,134

5,106

4,785

3,534

2,907

1,812

268

9,573

9,598

11,344

11,865

1,913

3,001

1,287

1,537

2,219

701

1,472

247

0

0

0

Accounts payable and accrued expenses

14,812

1,925

-4,434

-3,363

27,919

17,154

19,891

1,699

-14,079

-7,862

-1,946

-13,375

26,335

17,705

3,012

28,114

15,761

29,611

36,235

26,333

15,936

6,125

369

-229

-4,048

6,244

7,115

-1,278

1,814

-680

-3,565

7,832

4,763

3,660

0

0

0

Accrued compensation and benefits

30,397

32,758

19,025

16,558

14,589

10,252

20,453

19,608

17,774

13,430

12,372

4,784

1,016

19,142

5,942

20,196

20,667

11,888

19,597

16,759

11,503

11,515

10,214

9,035

7,425

6,367

16,169

2,596

5,676

5,794

-5,002

-1,191

-1,597

6,035

0

0

0

Other liabilities

-22,614

-6,090

-5,830

-8,244

2,148

-8,980

-13,753

-15,555

-26,765

-8,442

-2,701

7,053

10,893

8,147

7,998

-9,282

7,594

-2,103

-13,515

3,186

-475

-4,488

14,408

12,367

14,277

13,129

-321

-3,589

-1,711

-3,029

2,128

2,992

-3,565

-3,837

0

0

0

Deferred revenue

360

-1,806

-2,781

-3,279

-1,047

319

-164

309

-516

-548

1,154

3,491

362

732

429

-2,544

2,131

1,313

1,063

1,677

-626

-114

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash, cash equivalents and investments balance

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,176

6,332

9,002

10,114

8,108

7,176

4,301

0

0

0

-

-

-

-

-

-

-

-

Restricted investments balance

-63

-78

-93

6

44

92

94

-43

12

0

-878

-1,102

176

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

240,013

224,862

205,152

166,346

203,472

226,993

226,468

216,413

175,569

160,518

151,185

148,672

143,366

133,909

85,496

77,906

82,853

56,313

60,822

54,324

35,501

27,678

38,313

49,953

63,251

60,169

60,667

45,087

46,609

58,380

48,575

41,944

23,301

19,312

0

0

0

Cash flows from investing activities:
Purchase and development of fixed assets

41,401

35,218

36,060

34,281

36,891

35,206

33,283

31,245

26,734

26,529

21,419

20,803

20,836

21,956

23,593

25,300

27,258

27,010

25,969

23,862

19,661

19,134

16,887

13,575

12,675

9,047

8,166

8,610

6,686

5,472

4,851

4,407

3,962

4,648

0

0

0

Purchase of investments

23,426

26,309

23,398

40,363

39,100

33,824

31,260

14,587

12,378

15,096

24,173

20,403

17,956

13,152

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturity of investments

30,035

32,135

43,235

39,470

33,800

25,000

13,501

20,301

21,201

20,301

19,200

10,200

4,000

2,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in restricted cash, cash equivalents and investments balance

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-12,550

-11,140

-8,462

-4,336

-47

-104

475

560

617

667

93

-2,720

-2,717

0

0

0

Equity investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,000

5,000

3,000

2,000

0

0

0

0

-

-

-

-

-

-

-

-

Loan to Pipeline Health Holdings LLC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payments to fund deferred compensation plan

14,395

12,507

13,481

10,472

8,776

9,917

8,281

8,437

10,263

10,537

11,302

10,673

9,054

6,911

6,419

3,914

4,656

3,004

2,250

2,927

2,162

2,174

2,221

1,962

2,032

1,298

0

0

0

-

-

-

-

-

-

-

-

Purchase of convertible promissory note

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments to Acquire Businesses, Gross

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for other intangibles

2,550

1,240

1,120

1,120

1,270

1,180

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash received for working capital adjustments for prior year acquisitions

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments for Previous Acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

990

165

165

165

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales of assets held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,050

8,644

8,622

8,350

0

0

0

0

Net cash used in investing activities

-747,713

-291,824

-261,295

-281,078

-305,972

-279,337

-282,964

-254,695

-31,674

-35,361

-41,135

-44,823

-96,958

-258,361

-251,722

-254,373

-205,438

-116,085

-123,542

-117,285

-108,869

-28,228

-52,468

-48,975

-51,271

-49,198

-9,690

-10,775

-8,410

1,578

3,076

4,072

7,058

-1,981

0

0

0

Cash flows from financing activities:
Capital lease repayments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

61

220

377

529

674

676

679

681

637

638

640

650

662

669

675

673

0

0

0

Payments on term loans

-

-

-

-

-

-

-

-

-

44,063

203,438

188,126

165,938

167,813

10,313

9,375

8,438

7,500

7,500

7,500

157,120

155,245

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from term loans

400,000

150,000

0

0

0

-

-

-

-

-

-

-

-

75,000

75,000

75,000

75,000

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of Lines of Credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25,000

27,000

23,500

45,500

39,500

54,500

49,000

17,000

16,000

7,000

6,000

6,000

3,000

-8,300

-19,900

-19,900

-16,900

0

0

0

Proceeds from prior revolving credit facility

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

-

-

-

Proceeds from revolving credit facility

296,000

101,000

101,000

101,000

225,000

195,000

0

0

0

-

-

-

-

124,000

129,000

129,000

90,000

89,500

102,500

102,500

131,000

47,500

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

Repurchase of common stock

775

18,705

32,968

64,827

84,943

67,013

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of financing costs

9,122

5,223

875

777

0

2,331

2,331

2,331

2,331

0

6,113

6,113

6,113

6,561

448

448

448

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Earn-out payments for prior acquisitions

16,322

5,700

5,700

5,700

0

1,713

1,713

1,713

1,713

3,677

3,677

3,677

3,677

900

900

900

900

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of prior notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

211,125

215,750

21,377

13,875

0

0

0

Proceeds from exercise of equity awards

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,663

3,663

5,087

4,933

1,792

1,795

468

524

1,177

1,704

1,297

1,241

530

0

0

0

-

-

-

-

Cash paid for shares withheld for taxes

7,846

13,773

13,342

11,557

10,786

11,432

11,734

11,768

12,987

9,374

9,299

9,241

7,900

5,781

5,949

6,144

8,408

11,908

11,600

11,523

9,237

4,448

4,369

4,376

5,172

2,670

2,865

2,769

1,822

1,075

884

896

1,980

2,058

0

0

0

Excess tax benefit from equity awards vested and exercised

-

-

-

-

-

-

-

-

-

-

-

-

-

3,351

2,944

3,402

4,742

7,449

7,308

6,914

5,302

1,819

1,772

1,806

2,363

1,521

1,561

1,464

742

44

13

26

114

109

0

0

0

Change in bank overdraft

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-1,248

-3,860

-2,325

-948

0

0

0

Net cash provided by financing activities

590,935

136,599

92,177

108,139

54,271

37,511

68,405

80,337

-80,235

-77,193

-99,952

-101,818

-38,605

126,290

167,328

182,843

134,012

56,200

67,310

71,758

75,513

-2,099

-7,828

-5,830

-4,493

-1,017

-23,123

-39,296

-41,227

-58,169

-52,424

-38,482

-29,398

-15,300

0

0

0

Effect of exchange rate changes on cash

55

1

0

1

181

263

218

12

-121

-98

-9

104

232

267

198

212

46

75

155

176

219

142

-7

-166

-157

-55

-24

5

66

-70

-47

40

6

48

0

0

0

Net increase in cash, cash equivalents and restricted cash

83,290

69,638

36,034

-6,592

-48,048

-14,570

12,127

42,067

63,539

47,866

10,089

2,135

8,035

2,105

1,300

6,588

11,473

-3,497

4,745

8,973

2,364

-2,507

-21,990

-5,018

7,330

9,899

27,830

-4,979

-2,962

1,719

-820

7,574

967

2,079

0

0

0

Supplemental disclosures of cash flow information:
Cash paid for amounts included in the measurement of operating lease liabilities

18,213

17,817

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest (net of $159 and $102 capitalized for the three months ended March 31, 2020 and 2019, respectively)

24,104

23,730

24,750

22,830

22,606

21,283

20,062

18,974

17,592

17,936

10,346

12,508

6,307

8,057

8,578

7,748

6,771

5,806

5,246

4,575

4,341

4,599

6,839

5,932

6,594

7,405

6,959

9,864

11,577

13,698

15,148

18,601

19,561

19,667

0

0

0

Cash paid for income taxes

33,600

37,747

41,827

43,557

32,054

30,593

28,971

42,987

73,665

73,746

86,680

84,420

73,760

73,366

65,161

59,860

35,077

33,132

25,803

16,092

18,130

17,880

16,889

18,690

14,212

18,865

16,205

10,891

6,620

1,860

-755

-469

168

388

0

0

0

Business Combinations [Abstract]
Acquisitions:
Fair value of tangible assets acquired in acquisitions, net of cash and restricted cash received

65,859

29,660

28,541

28,123

25,067

24,026

0

0

0

-

-

-

-

18,703

19,220

19,335

13,850

26,771

27,971

27,243

27,258

1,631

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

386,516

157,036

148,302

149,313

124,404

97,910

0

0

0

-

-

-

-

136,101

139,857

144,628

109,056

50,227

56,641

52,523

52,452

9,750

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets

352,700

107,580

98,579

96,180

128,990

122,110

0

0

0

-

-

-

-

89,064

89,709

93,102

73,862

34,237

43,552

40,179

40,179

9,960

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Liabilities assumed

96,580

31,148

35,079

34,032

19,976

16,586

0

0

0

-

-

-

-

21,474

22,349

23,187

14,490

22,954

26,347

25,480

25,424

3,821

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Holdback provision

-

-

-

-

-

-

-

-

-

-

-

-

-

1,830

2,830

3,622

3,622

1,500

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Earn-out liabilities

13,722

15,222

12,122

12,122

11,600

10,100

0

0

0

-

-

-

-

4,070

4,070

6,770

6,290

2,700

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash paid for acquisitions

694,773

247,906

228,221

227,462

246,885

217,360

0

0

0

-

-

-

-

216,494

219,537

223,486

172,366

84,081

95,567

91,415

91,415

14,470

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosures of non-cash investing and financing activities:
Purchase of fixed assets recorded in accounts payable and accrued expenses

1,521

2,301

-656

2,258

1,412

1,706

4,310

2,523

3,382

2,962

3,920

2,653

2,085

2,134

2,501

2,451

2,219

3,337

3,073

4,070

5,158

4,618

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-